Your browser doesn't support javascript.
loading
Rational Design of Amphipathic Antimicrobial Peptides with Alternating L-/D-Amino Acids That Form Helical Structures.
Hirano, Motoharu; Yokoo, Hidetomo; Ohoka, Nobumichi; Ito, Takahito; Misawa, Takashi; Oba, Makoto; Inoue, Takao; Demizu, Yosuke.
Afiliación
  • Hirano M; National Institute of Health Sciences.
  • Yokoo H; Graduate School of Medical Life Science, Yokohama City University.
  • Ohoka N; National Institute of Health Sciences.
  • Ito T; Medical Chemistry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine.
  • Misawa T; National Institute of Health Sciences.
  • Oba M; National Institute of Health Sciences.
  • Inoue T; Graduate School of Medical Life Science, Yokohama City University.
  • Demizu Y; National Institute of Health Sciences.
Chem Pharm Bull (Tokyo) ; 72(2): 149-154, 2024.
Article en En | MEDLINE | ID: mdl-38296556
ABSTRACT
Antimicrobial peptides (AMPs) are promising therapeutic agents against bacteria. We have previously reported an amphipathic AMP Stripe composed of cationic L-Lys and hydrophobic L-Leu/L-Ala residues, and Stripe exhibited potent antimicrobial activity against Gram-positive and Gram-negative bacteria. Gramicidin A (GA), composed of repeating sequences of L- and D-amino acids, has a unique ß6.3-helix structure and exhibits broad antimicrobial activity. Inspired by the structural properties and antimicrobial activities of LD-alternating peptides such as GA, in this study, we designed Stripe derivatives with LD-alternating sequences. We found that simply alternating L- and D-amino acids in the Stripe sequence to give StripeLD caused a reduction in antimicrobial activity. In contrast, AltStripeLD, with cationic and hydrophobic amino acids rearranged to yield an amphipathic distribution when the peptide adopts a ß6.3-helix, displayed higher antimicrobial activity than AltStripe. These results suggest that alternating L-/D-cationic and L-/D-hydrophobic amino acids in accordance with the helical structure of an AMP may be a useful way to improve antimicrobial activity and develop new AMP drugs.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aminoácidos / Antibacterianos Idioma: En Revista: Chem Pharm Bull (Tokyo) Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aminoácidos / Antibacterianos Idioma: En Revista: Chem Pharm Bull (Tokyo) Año: 2024 Tipo del documento: Article